DM0000: The mark consists of the word "BENDEKA" in capital orange letters with the words "bendamustine HCI" in lower case gray letters directly underneath in parenthesis and the word "injection" in lower case gray letters directly underneath. There is a tilted triangle shape of gray, lime green and orange ribbons directly to the left of the word "BENDEKA".
CC0000: The color(s) orange, lime green and gray is/are claimed as a feature of the mark.
GS0441: Providing an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma
D10000: "BENDAMUSTINE HCI" AND "INJECTION"
Case File Event Statements
2/17/2023 - a year ago
41 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILEDType:NA85
2/17/2023 - a year ago
40 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A
2/17/2023 - a year ago
39 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
2/2/2023 - a year ago
38 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
2/2/2023 - a year ago
37 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINSType:EWAF